Søgeresultater - Alejandro Moreno‐Koehler
- Showing 1 - 2 results of 2
-
1
Estimation of minimally important differences and responder definitions for EORTC QLQ‐MY20 scores in multiple myeloma patients af Kate Sully, Andrew Trigg, Nicola Bonner, Alejandro Moreno‐Koehler, Claire Trennery, Nina Shah, Emre Yücel, Sumeet Panjabi, Kim Cocks
Udgivet 2019Artigo -
2
First-Line Nivolumab Plus Ipilimumab Versus Chemotherapy in Advanced NSCLC With 1% or Greater Tumor PD-L1 Expression: Patient-Reported Outcomes From CheckMate 227 Part 1 af Martin Reck, Tudor‐Eliade Ciuleanu, Jong Seok Lee, Michael Schenker, Clarisse Audigier-Valette, Bogdan Żurawski, Helena Linardou, Gregory A. Otterson, Pamela Salman, Makoto Nishio, Emmanuel de la Mora Jimenez, Krysztof Lesniewski-Kmak, István Albert, Samreen Ahmed, Konstantinos Syrigos, John R. Penrod, Yong Yuan, Steven I. Blum, Faith E. Nathan, Xiaowu Sun, Alejandro Moreno‐Koehler, Fiona Taylor, Kenneth J. O’Byrne
Udgivet 2021Artigo
Søgeredskaber:
Relaterede emner
Internal medicine
Medicine
Cancer
Chemotherapy
Clinical trial
Confidence interval
Environmental health
Hazard ratio
Immunotherapy
Ipilimumab
Lung cancer
Minimal clinically important difference
Multiple myeloma
Nivolumab
Nursing
Oncology
Physical therapy
Physics
Population
Psychological intervention
Quality of life (healthcare)
Quantum mechanics
Randomized controlled trial
Scale (ratio)
Surgery
Visual analogue scale